Axsome Therapeutics (AXSM) Tax Provisions (2017 - 2025)
Axsome Therapeutics (AXSM) reported Tax Provisions of $502000.0 for Q4 2025, up 490.59% on a YoY basis from $85000.0 in Q4 2024, and up 152.29% sequentially from -$960000.0 in Q2 2025.
Axsome Therapeutics (AXSM) Tax Provisions (2017 - 2025) Analysis & Trends
Axsome Therapeutics (AXSM) has 5 years of Tax Provisions data on file, last reported at $502000.0 in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions rose 490.59% year-over-year to $502000.0; the trailing twelve-month figure through Mar 2026 stood at -$458000.0 (down 638.82% YoY), and the FY2025 full-year result was -$498000.0, down 685.88% from the prior year.
- Tax Provisions advanced to $502000.0 in Q4 2025, from -$960000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $2.6 million in Q1 2023 to a low of -$960000.0 in Q2 2025.
- A 3-year average of $87000.0 and a median of -$340000.0 in 2023 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions soared 125.0% in 2024 and surged 490.59% in 2025, its largest moves.
- Tracing AXSM's Tax Provisions over 3 years: stood at -$340000.0 in 2023, then soared by 125.0% to $85000.0 in 2024, then surged by 490.59% to $502000.0 in 2025.
- Business Quant data shows AXSM's Tax Provisions at $502000.0 in Q4 2025, -$960000.0 in Q2 2025, and $85000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Axsome Therapeutics | 12.37 Bn | 12.06 Bn | 176.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 502,000.00 |
| Jun 30, 2025 | -960,000.00 |
| Dec 31, 2024 | 85,000.00 |
| Dec 31, 2023 | -340,000.00 |
| Sep 30, 2023 | -678,000.00 |
| Jun 30, 2023 | -600,000.00 |
| Mar 31, 2023 | 2.60 Mn |
| Sep 30, 2018 | -217,418.00 |
| Sep 30, 2017 | -207,114.00 |